Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Chubb
Accenture
Argus Health
AstraZeneca
Daiichi Sankyo
Colorcon
Federal Trade Commission

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 061996

« Back to Dashboard

NDA 061996 describes FULVICIN P/G 330, which is a drug marketed by Chartwell Rx and is included in one NDA. Additional details are available on the FULVICIN P/G 330 profile page.

The generic ingredient in FULVICIN P/G 330 is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.
Summary for 061996
Tradename:FULVICIN P/G 330
Applicant:Chartwell Rx
Ingredient:griseofulvin, ultramicrocrystalline
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength125MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength165MG
Approval Date:Apr 6, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Cerilliant
Healthtrust
Federal Trade Commission
Cantor Fitzgerald
US Department of Justice
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.